MECLIZINE

Meclizine Adverse Events Reported to the FDA Over Time

How are Meclizine adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Meclizine, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Meclizine is flagged as the suspect drug causing the adverse event.

Most Common Meclizine Adverse Events Reported to the FDA

What are the most common Meclizine adverse events reported to the FDA?

Drug Ineffective	127 (7.29%)
Dizziness	93 (5.34%)
Completed Suicide	36 (2.07%)
Nausea	27 (1.55%)
Somnolence	26 (1.49%)
Hypersensitivity	24 (1.38%)
Headache	23 (1.32%)
Malaise	23 (1.32%)
Vertigo	20 (1.15%)
Drug Hypersensitivity	19 (1.09%)
Drug Exposure During Pregnancy	17 (.98%)
	Show More
Fatigue	17 (.98%)
Depression	15 (.86%)
Drug Toxicity	15 (.86%)
Fall	15 (.86%)
Feeling Abnormal	15 (.86%)
Asthenia	14 (.8%)
Dysarthria	14 (.8%)
Asthma	13 (.75%)
Hyperhidrosis	13 (.75%)
Hypotension	13 (.75%)
Respiratory Arrest	12 (.69%)
Diabetes Mellitus	11 (.63%)
Drug Interaction	11 (.63%)
Dyspnoea	11 (.63%)
Hypertension	11 (.63%)
Vision Blurred	11 (.63%)
Balance Disorder	10 (.57%)
Cardiac Arrest	10 (.57%)
Muscle Twitching	10 (.57%)
Amnesia	9 (.52%)
Anaemia	9 (.52%)
Anxiety	9 (.52%)
Cardio-respiratory Arrest	9 (.52%)
Confusional State	9 (.52%)
Death	9 (.52%)
Hallucination	9 (.52%)
Overdose	9 (.52%)
Syncope	9 (.52%)
Convulsion	8 (.46%)
Diarrhoea	8 (.46%)
Loss Of Consciousness	8 (.46%)
Vomiting	8 (.46%)
Abdominal Discomfort	7 (.4%)
Condition Aggravated	7 (.4%)
Diplopia	7 (.4%)
Drug Effect Decreased	7 (.4%)
Gait Disturbance	7 (.4%)
Incorrect Dose Administered	7 (.4%)
Medication Error	7 (.4%)
Memory Impairment	7 (.4%)
Palpitations	7 (.4%)
Prostate Cancer	7 (.4%)
Psychotic Disorder	7 (.4%)
Tremor	7 (.4%)
Weight Decreased	7 (.4%)
Blood Cholesterol Abnormal	6 (.34%)
Blood Glucose Decreased	6 (.34%)
Blood Pressure Fluctuation	6 (.34%)
Body Height Decreased	6 (.34%)
Coronary Artery Bypass	6 (.34%)
Gastrooesophageal Reflux Disease	6 (.34%)
Hallucination, Visual	6 (.34%)
Hot Flush	6 (.34%)
Influenza Like Illness	6 (.34%)
Product Substitution Issue	6 (.34%)
Rash	6 (.34%)
Spinal Column Stenosis	6 (.34%)
Weight Increased	6 (.34%)
Activities Of Daily Living Impaired	5 (.29%)
Alcohol Use	5 (.29%)
Blood Pressure Increased	5 (.29%)
Cardiac Disorder	5 (.29%)
Coma	5 (.29%)
Dehydration	5 (.29%)
Dyskinesia	5 (.29%)
Erectile Dysfunction	5 (.29%)
Eye Disorder	5 (.29%)
Eyelid Ptosis	5 (.29%)
Fluid Retention	5 (.29%)
Insomnia	5 (.29%)
Nervousness	5 (.29%)
Oedema Peripheral	5 (.29%)
Orthostatic Hypotension	5 (.29%)
Pain In Extremity	5 (.29%)
Pelvic Fracture	5 (.29%)
Strabismus	5 (.29%)
Tinnitus	5 (.29%)
Alopecia	4 (.23%)
Angioplasty	4 (.23%)
Arthralgia	4 (.23%)
Bladder Neoplasm	4 (.23%)
Blood Cholesterol Increased	4 (.23%)
Blood Testosterone Decreased	4 (.23%)
Central Nervous System Lesion	4 (.23%)
Chest Discomfort	4 (.23%)
Clavicle Fracture	4 (.23%)
Cleft Palate	4 (.23%)
Cough	4 (.23%)
Cyst	4 (.23%)
Cystic Lymphangioma	4 (.23%)

Share/Embed Graph Export Data

This graph shows the top adverse events submitted to the FDA for Meclizine, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Meclizine is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Meclizine

What are the most common Meclizine adverse events reported to the FDA?

Neurological	193 (11.08%)
Therapeutic And Nontherapeutic Effe...	159 (9.13%)
Allergic Conditions	52 (2.99%)
Gastrointestinal Signs	52 (2.99%)
Medication Errors	52 (2.99%)
Chemical Injury And Poisoning	38 (2.18%)
Suicidal And Self-injurious Behavio...	36 (2.07%)
Injuries	35 (2.01%)
Vision	31 (1.78%)
Inner Ear And Viiith Cranial Nerve	30 (1.72%)
Respiratory	30 (1.72%)
	Show More
Cardiac Arrhythmias	29 (1.66%)
Disturbances In Thinking	27 (1.55%)
Decreased And Nonspecific Blood Pre...	25 (1.44%)
Headaches	25 (1.44%)
Anxiety Disorders	21 (1.21%)
Mental Impairment	21 (1.21%)
Movement Disorders	20 (1.15%)
Physical Examination Topics	20 (1.15%)
Gastrointestinal Motility And Defec...	19 (1.09%)
Lifestyle Issues	18 (1.03%)
Skin Appendage Conditions	18 (1.03%)
Cardiac And Vascular Investigations	17 (.98%)
Epidermal And Dermal Conditions	17 (.98%)
Muscle	17 (.98%)
Bronchial Disorders	16 (.92%)
Electrolyte And Fluid Balance Condi...	16 (.92%)
Bone And Joint Injuries	15 (.86%)
Depressed Mood Disorders	15 (.86%)
Glucose Metabolism Disorders	14 (.8%)
Joint	14 (.8%)
Ocular Neuromuscular	14 (.8%)
Cardiac Disorder Signs	13 (.75%)
Deliria	13 (.75%)
Fatal Outcomes	12 (.69%)
Lipid Analyses	12 (.69%)
Sleep Disorders	12 (.69%)
Vascular Therapeutic Procedures	12 (.69%)
Bone And Joint Therapeutic Procedur...	11 (.63%)
Infections - Pathogen Unspecified	11 (.63%)
Seizures	11 (.63%)
Vascular Hypertensive	11 (.63%)
Appetite And General Nutritional	10 (.57%)
Anemias Nonhemolytic And Marrow Dep...	9 (.52%)
Hepatic And Hepatobiliary	9 (.52%)
Musculoskeletal And Connective Tiss...	9 (.52%)
Psychiatric	9 (.52%)
Vascular	9 (.52%)
Eye	8 (.46%)
Gastrointestinal Tract Disorders Co...	8 (.46%)
Musculoskeletal And Connective Tiss...	8 (.46%)
Musculoskeletal And Connective Tiss...	8 (.46%)
Product Quality Issues	8 (.46%)
Cardiac And Vascular Disorders Cong...	7 (.4%)
Hematology Investigations	7 (.4%)
Metabolic, Nutritional And Blood Ga...	7 (.4%)
Renal Disorders	7 (.4%)
Reproductive Neoplasms Male Maligna...	7 (.4%)
Schizophrenia And Other Psychotic	7 (.4%)
Therapeutic Procedures And Supporti...	7 (.4%)
Hearing	6 (.34%)
Mood Disorders	6 (.34%)
Renal And Urinary Tract Investigati...	6 (.34%)
Renal And Urinary Tract Neoplasms M...	6 (.34%)
Tissue	6 (.34%)
Angiedema And Urticaria	5 (.29%)
Body Temperature Conditions	5 (.29%)
Bone, Calcium, Magnesium And Phosph...	5 (.29%)
Central Nervous System Vascular	5 (.29%)
Coronary Artery	5 (.29%)
Exocrine Pancreas Conditions	5 (.29%)
Leukemias	5 (.29%)
Malabsorption Conditions	5 (.29%)
Neuromuscular	5 (.29%)
Ocular Sensory Symptoms	5 (.29%)
Psychiatric And Behavioural Symptom...	5 (.29%)
Sexual Function And Fertility	5 (.29%)
Upper Respiratory Tract Disorders	5 (.29%)
Urinary Tract Signs	5 (.29%)
White Blood Cell	5 (.29%)
Blood And Lymphatic System Disorder...	4 (.23%)
Dental And Gingival Conditions	4 (.23%)
Endocrine Investigations	4 (.23%)
Personality Disorders	4 (.23%)
Salivary Gland Conditions	4 (.23%)
Sleep Disturbances	4 (.23%)
Testicular And Epididymal	4 (.23%)
Abortions And Stillbirth	3 (.17%)
Bacterial Infectious	3 (.17%)
Cardiac Valve	3 (.17%)
Chromosomal Abnormalities And Abnor...	3 (.17%)
Ear And Labyrinthine Disorders Cong...	3 (.17%)
Lower Respiratory Tract Disorders	3 (.17%)
Menstrual Cycle And Uterine Bleedin...	3 (.17%)
Middle Ear Disorders	3 (.17%)
Pleural	3 (.17%)
Thyroid Gland	3 (.17%)
Urolithiases	3 (.17%)
Vascular Hemorrhagic	3 (.17%)
Viral Infectious	3 (.17%)
Abdominal Hernias And Other Abdomin...	2 (.11%)

Share/Embed Graph Export Data

This graph shows the top categories of adverse events submitted to the FDA for Meclizine, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Meclizine is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.